Cord Blood Banking Market (By Type of Bank: Public, Private; By Services: Processing, Storage, Others; By Application: Cancer, Blood Disorders, Bone Marrow Failure Syndrome, Immuno-deficiency Disorders, Metabolic Disorders; By End Use: Hospital, Research Institutes, Specialty Clinics, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Cord Blood Banking Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Cord Blood Banking Market, by Type of Bank, 2024-2033
8.1.1. Public
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Private
8.1.2.1. Market Revenue and Forecast (2021-2033)
9.1. Cord Blood Banking Market, by Services, 2024-2033
9.1.1. Processing
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Storage
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2021-2033)
10.1. Cord Blood Banking Market, by Application, 2024-2033
10.1.1. Cancer
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Blood Disorders
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Bone Marrow Failure Syndrome
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Immuno-deficiency Disorders
10.1.4.1. Market Revenue and Forecast (2021-2033)
10.1.5. Metabolic Disorders
10.1.5.1. Market Revenue and Forecast (2021-2033)
11.1. Cord Blood Banking Market, by End Use, 2024-2033
11.1.1. Hospital
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Research Institutes
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Specialty Clinics
11.1.3.1. Market Revenue and Forecast (2021-2033)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2021-2033)
12.1. North America
12.1.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.1.2. Market Revenue and Forecast, by Services (2021-2033)
12.1.3. Market Revenue and Forecast, by Application (2021-2033)
12.1.4. Market Revenue and Forecast, by End Use (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.1.5.2. Market Revenue and Forecast, by Services (2021-2033)
12.1.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.1.5.4. Market Revenue and Forecast, by End Use (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.1.6.2. Market Revenue and Forecast, by Services (2021-2033)
12.1.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.1.6.4. Market Revenue and Forecast, by End Use (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.2.2. Market Revenue and Forecast, by Services (2021-2033)
12.2.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.4. Market Revenue and Forecast, by End Use (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.2.5.2. Market Revenue and Forecast, by Services (2021-2033)
12.2.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.5.4. Market Revenue and Forecast, by End Use (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.2.6.2. Market Revenue and Forecast, by Services (2021-2033)
12.2.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.6.4. Market Revenue and Forecast, by End Use (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.2.7.2. Market Revenue and Forecast, by Services (2021-2033)
12.2.7.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.7.4. Market Revenue and Forecast, by End Use (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.2.8.2. Market Revenue and Forecast, by Services (2021-2033)
12.2.8.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.8.4. Market Revenue and Forecast, by End Use (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.3.2. Market Revenue and Forecast, by Services (2021-2033)
12.3.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.4. Market Revenue and Forecast, by End Use (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.3.5.2. Market Revenue and Forecast, by Services (2021-2033)
12.3.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.5.4. Market Revenue and Forecast, by End Use (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.3.6.2. Market Revenue and Forecast, by Services (2021-2033)
12.3.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.6.4. Market Revenue and Forecast, by End Use (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.3.7.2. Market Revenue and Forecast, by Services (2021-2033)
12.3.7.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.7.4. Market Revenue and Forecast, by End Use (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.3.8.2. Market Revenue and Forecast, by Services (2021-2033)
12.3.8.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.8.4. Market Revenue and Forecast, by End Use (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.4.2. Market Revenue and Forecast, by Services (2021-2033)
12.4.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.4. Market Revenue and Forecast, by End Use (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.4.5.2. Market Revenue and Forecast, by Services (2021-2033)
12.4.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.5.4. Market Revenue and Forecast, by End Use (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.4.6.2. Market Revenue and Forecast, by Services (2021-2033)
12.4.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.6.4. Market Revenue and Forecast, by End Use (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.4.7.2. Market Revenue and Forecast, by Services (2021-2033)
12.4.7.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.7.4. Market Revenue and Forecast, by End Use (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.4.8.2. Market Revenue and Forecast, by Services (2021-2033)
12.4.8.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.8.4. Market Revenue and Forecast, by End Use (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.5.2. Market Revenue and Forecast, by Services (2021-2033)
12.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.5.4. Market Revenue and Forecast, by End Use (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.5.5.2. Market Revenue and Forecast, by Services (2021-2033)
12.5.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.5.5.4. Market Revenue and Forecast, by End Use (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Type of Bank (2021-2033)
12.5.6.2. Market Revenue and Forecast, by Services (2021-2033)
12.5.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.5.6.4. Market Revenue and Forecast, by End Use (2021-2033)
13.1. Thermo Fisher Scientific (US)
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Merck KGaA (Germany)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Lonza Group (Switzerland)
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. STEMCELL Technologies (Canada)
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Takara Bio (Japan)
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. FUJIFILM Cellular Dynamics (US)
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Sartorius AG (Germany)
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. GE Healthcare (UK)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Charles River Laboratories International (US)
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Cynata Therapeutics (Australia)
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample